Dr. Reddy’s Laboratories is a multinational pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and services. Through its businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations. The company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe.

Dr. Reddy's Lab major competitors are Mankind Pharma, Zydus Lifesciences, Torrent Pharma, Lupin, Cipla, Abbott India, Alkem Laboratories.
Market Cap of Dr. Reddy's Lab is ₹1,09,380 Crs.
While the median market cap of its peers are ₹1,04,145 Crs.

Dr. Reddy's Lab seems to be less financially stable compared to its competitors.
Altman Z score of Dr. Reddy's Lab is 7.04 and is ranked 7 out of its 8 competitors.